← Leaderboards
Yinduo Ji
University Of Minnesota Twin Cities
$2,484,943
Attributed
$2,484,943
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $477.3K · FY2005–12$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
Funding mix
By agency
NIH$2,484,943 · 3
By mechanism
R01$2,081,712 · 2
R21$403,231 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Minnesota Twin Cities
Same institution · by research overlap
- Hung-Wen Liu$20,748,384
Others in their field
Top investigators on “Vancomycin”
- Vance G Fowler · Duke University$40,113,758
- Henry F Chambers · Duke University$36,808,878
- David S Perlin · Hackensack University Medical Center$33,316,814
- Cesar Augusto Arias · Methodist Hospital Research Institute$14,922,448
- Michael Lafleur · Arietis$14,152,847
- Daniel E Kahne · Harvard University$13,401,150
Research focus
VancomycinInhibitor/AntagonistTherapeutic InterventionPublic Health Medicine (Field)BacteriaIntermediate ResistancePreventiveTherapeutic AgentsLeadPromotor (Genetics)Down-RegulationStaphylococcus AureusRna InterferenceBaseGrowthPathogenGenesCellsInfectionHomologous GeneSkinLuciferasesMonitorPhenotype
Grant awards (9)
Biomarker Screening of Essential Putative Glycoprotease Inhibitor$373,725
R01 · FY2012 · AI · contact PI
Biomarker Screening of Essential Putative Glycoprotease Inhibitor$373,725
R01 · FY2011 · AI · contact PI
Biomarker Screening of Essential Putative Glycoprotease Inhibitor$364,980
R01 · FY2010 · AI · contact PI
A Novel Essential Regulator of Staphylococcus aureus$243,355
R01 · FY2008 · AI · contact PI
A Novel Essential Regulator of Staphylococcus aureus$248,068
R01 · FY2007 · AI · contact PI
Novel antibacterial target: an essential glycoprotease$181,456
R21 · FY2007 · AI · contact PI
A Novel Essential Regulator of Staphylococcus aureus$255,478
R01 · FY2006 · AI · contact PI
Novel antibacterial target: an essential glycoprotease$221,775
R21 · FY2006 · AI · contact PI
A Novel Essential Regulator of Staphylococcus aureus$222,381
R01 · FY2005 · AI